This FDA's Update on Draft Guidance webinar will provide an overview to companies who need to learn how FDA evaluates risk communication in promotional materials and what factors are considered for Drug and Device Promotion.
Areas Covered in the seminar:
* Learn what factors are considered in the review of risk communication.
* Understand what important factors relate to both the content and the format of a promotional piece.
* How FDA evaluates risk communication in a "promo" piece.
* Understand and relate to the additional considerations of content and expectations.
* What is SUPER and the impact on risk disclosure?
* Learn why this is a draft guidance that will minimize risk of disseminating false or misleading information.
* Understand why manufacturers should focus not just on individual claims/presentations, but on the messages conveyed by the promotional piece as a whole.
* Guidance was issued in May 2009 but does provide a better understanding of what FDA expects to mitigate your compliance exposure.
Please contact Customer Care to avail 15% Christmas Offer on Regular Pricing (650-620-3937)
Send to friendSign In to get started!
